UBS ASSET MANAGEMENT AMERICAS LLC - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 109 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$25,463,335,000
+28.3%
225,140
+13.6%
0.02%
+25.0%
Q1 2017$19,847,768,000
+101725.2%
198,220
+9.3%
0.02%
-9.1%
Q4 2016$19,492,000
-12.1%
181,287
+1.8%
0.02%
-8.3%
Q3 2016$22,167,000
+3.6%
178,070
-11.5%
0.02%0.0%
Q2 2016$21,399,000
-4.0%
201,265
+3.3%
0.02%
-7.7%
Q1 2016$22,295,000
-18.0%
194,756
+2.1%
0.03%
-16.1%
Q4 2015$27,179,000
+58.4%
190,779
-0.1%
0.03%
+63.2%
Q3 2015$17,156,000
-7.8%
191,010
+18.2%
0.02%
+5.6%
Q2 2015$18,613,000161,6290.02%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q2 2015
NameSharesValueWeighting ↓
SPQ Asia Capital Ltd 287,277$35,760,00028.32%
WARBURG PINCUS LLC 6,674$830,780,00013.45%
Ariose Capital Management Ltd 238,841$27,689,0007.56%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 12,600$1,568,0004.48%
RUDMAN ERROL M 37,001$4,606,0003.72%
INDUS CAPITAL PARTNERS, LLC 245,237$30,527,0002.89%
Ativo Capital Management LLC 93,784$11,674,0002.70%
OBERWEIS ASSET MANAGEMENT INC/ 63,305$7,880,0002.27%
Point72 Hong Kong Ltd 31,500$3,921,0002.14%
Cormorant Asset Management, LP 112,867$14,050,0001.55%
View complete list of CHINA BIOLOGIC PRODS INC shareholders